SARS COV-2- IgG antibodies in blood donors in pandemic – A game changer for policy makers

BACKGROUND: A novel beta coronavirus, named Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), has been identified as the causative pathogen for the present pandemic. The objective of the study was to measure the levels of IgG antibodies targeting the SARS-CoV-2 during the peak period of...

Descripción completa

Detalles Bibliográficos
Autor principal: Mahapatra, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS on behalf of Société française de transfusion sanguine (SFTS). 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511886/
https://www.ncbi.nlm.nih.gov/pubmed/34653615
http://dx.doi.org/10.1016/j.tracli.2021.10.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511886/
https://www.ncbi.nlm.nih.gov/pubmed/34653615
http://dx.doi.org/10.1016/j.tracli.2021.10.004

Ejemplares similares